Neuroleptic malignant syndrome associated with metoclopramide. 1985

M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke

UI MeSH Term Description Entries
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009459 Neuroleptic Malignant Syndrome A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72) Neuroleptic-Induced Neuroleptic Malignant Syndrome,Neuroleptic-Malignant Syndrome, Neuroleptic Induced,NMS (Neuroleptic Malignant Syndrome),NMSs (Neuroleptic Malignant Syndrome),Neuroleptic Induced Neuroleptic Malignant Syndrome,Neuroleptic Malignant Syndrome, Neuroleptic Induced,Neuroleptic Malignant Syndromes,Syndrome, Neuroleptic Malignant,Syndromes, Neuroleptic Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
January 1988, British medical journal (Clinical research ed.),
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
May 1988, Southern medical journal,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
May 1999, The Annals of pharmacotherapy,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
February 1992, Gynecologic oncology,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
January 2014, The Turkish journal of pediatrics,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
January 1993, Neurology India,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
August 1987, Archives of internal medicine,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
January 2006, Journal of burn care & research : official publication of the American Burn Association,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
January 1991, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M B Robinson, and R P Kennett, and A E Harding, and N J Legg, and B Clarke
January 2023, Anaesthesiology intensive therapy,
Copied contents to your clipboard!